Copyright
©The Author(s) 2022.
World J Clin Cases. Jun 26, 2022; 10(18): 6141-6147
Published online Jun 26, 2022. doi: 10.12998/wjcc.v10.i18.6141
Published online Jun 26, 2022. doi: 10.12998/wjcc.v10.i18.6141
No | Ref. | Sex/Age (yr) | Duration after injection (mo/wk/d) | Skin symptoms | Site of infection | Culture | Treatment and course | Outcome |
P1 | The present case | F/53 | Botulinum toxin (1.5 mo) | Erythematousnodules | Cheek, forehead | M. abscessus | Clarithromycin, moxifloxacin, amikacin 2/d (7 mo) | Cure |
P2 | Chen et al[2] | F/32 | Botulinum toxin (2 mo) | Nodules and abscesses | Forehead and periorbial areas | M. abscessus | Clarithromycin 250 mg 2/d, rifampicin 450 mg 1/d, and ethambutol 250 mg 3/d (3 mo) | Cure |
P3 | Chen et al[2] | F/34 | Botulinum toxin (10 d) | Painful papules and nodules | Lower jaw, malar, and temple regions | M. abscessus | Clarithromycin 250 mg 2/d, rifampicin 450 mg 1/d (6 mo) | Cure |
P4 | Mello et al[3] | F/28 | Sunflower oil, deoxycholate, sinetrol, and caffeine subcutaneous application (4 wk) | Pain and erythema | Abdomen and flanks | M. lentiflavum | Clarithromycin, 500 mg 2/d and levofloxacin 500 mg 1/d (8 mo) | Cure |
P5 | Tan et al[4] | F/36.6 (28-45) (5 cases) | Autologous fat grafting for cosmetic breast augmentation (20 d) | Erythema, breast contour disruption, breast asymmetry | Breast | M. Fortuitum (2), M. abscessus (1), and M. chelonei (2) | Clarithromycin 500 mg 2/d, amikacin 800 mg 1/d, and imipenem 500 mg 4/d (54 wk) Azithromycin 500 mg 1/d, ethambutol 750 mg 1/d, rifampicin 600 mg 1/d (6 mo), and surgical debridement | Cure |
P6 | Yeon et al[6] | F/34 | Botulinum toxin (3.5 mo) | Erythematousnodules | Left mandible | M. immunogemom | Clarithromycin 500 mg 2/d (7 m) | Cure |
P7 | Fang et al[7] | F/28 | Botulinum toxin (2 wk) | Erythemaand painful nodules | Lower extremities | M. abscessus | Clarithromycin, moxifloxacin, and rifampicin (6 mo) | Cure |
P8 | Thanas arnaksorn et al[8] | F/42 | Botulinum toxin (5 wk) | Erythematous nodules | Frontalis area and right orbicularis oculi area | Histopathologically confirmed | Clarithromycin 500 mg/d and levofloxacin500 mg/d (6 mo) | Cure |
P9 | Saeb-Lima et al[9] | F/45 | Botulinum toxin (5 mo) | Erythematousplaques and nodules | Procerus muscle zone and the pars externa of orbicularis oculi muscle | Histopathologically confirmed | Clarithromycin, azithromycin, and rifampicin (40 d) | Cure |
P10 | Hammond et al[10] | F/40 | Lipofilling (2 mo) | Multiple painful nodules | Buttock | M. chelonae | Clarithromycin 500 mg 2/d (2.5 mo), ciprofloxacin 500mg 2/d (3 mo), and surgery | Cure |
P11 | Yoo et al[11] | F/56 | Filler injections (3 mo) | Nodules | Cheek | M. volinskyi | Doxycycline 100 mg 2/d and ciprofloxacin 750 mg 6/d (5 mo) | Cure |
P12 | Fiore et al[12] | F/31 | Poly-L-lactic acid (3 mo) | Erythematous nodules | Cheek | M. mucogenicum | Ciprofloxacin 500 mg and clarithromycin 500 mg 2/d (6 mo) | Cure |
P13 | Eustace et al[13] | M/28 | Hair transplant (2 mo) | Nodules | Sculp | M. abscessus | Clarithromycin 250 mg 2/d, doxycycline 100 mg 1/d (3 mo), and drainage | Cure |
P14 | Yang et al[14] | F/29 | Facial injection with autologous fat (9 mo) | Abscesses | Temporal and lower orbital regions | M. abscessus | Moxifloxacin, clarithromycin, and ethambutol (12 mo) | Cure |
- Citation: Deng L, Luo YZ, Liu F, Yu XH. Subcutaneous infection caused by Mycobacterium abscessus following cosmetic injections of botulinum toxin: A case report. World J Clin Cases 2022; 10(18): 6141-6147
- URL: https://www.wjgnet.com/2307-8960/full/v10/i18/6141.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i18.6141